Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature

Abstract

The transcriptional activation and repression during NK cell ontology are poorly understood. Here, using single-cell RNA-sequencing, we reveal a novel role for T-bet in suppressing the immature gene signature during murine NK cell development. Based on transcriptome, we identified five distinct NK cell clusters and define their relative developmental maturity in the bone marrow. Transcriptome-based machine-learning classifiers revealed that half of the mTORC2-deficient NK cells belongs to the least mature NK cluster. Mechanistically, loss of mTORC2 results in an increased expression of signature genes representing immature NK cells. Since mTORC2 regulates the expression of T-bet through AktS473-FoxO1 axis, we further characterized the T-bet-deficient NK cells and found an augmented immature transcriptomic signature. Moreover, deletion of Foxo1 restores the expression of T-bet and corrects the abnormal expression of immature NK genes. Collectively, our study reveals a novel role for mTORC2-AktS473-FoxO1-T-bet axis in suppressing the transcriptional signature of immature NK cells.

Data availability

Sequencing data have been deposited in GEO under accession code GSE150166

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Chao Yang

    Laboratory of Molecular Immunology and Immunotherapy, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Jason R Siebert

    Laboratory of Molecular Immunology and Immunotherapy, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Robert Burns

    Blood Research Institute, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Yongwei Zheng

    Laboratory of B-Cell Lymphopoiesis, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ao Mei

    Laboratory of Molecular Immunology and Immunotherapy, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Benedetta Bonacci

    Flow Cytometry Core, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Demin Wang

    Laboratory of B-Cell Lymphopoiesis, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Raul A Urrutia

    Surgery, Medical College of Wisconsin, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Matthew J Riese

    Laboratory of Lymphocyte Biology, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Sridhar Rao

    Laboratory of Stem Cell Transcriptional Regulation, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Karen-Sue Carlson

    Laboratory of Coagulation Biology, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Monica S Thakar

    Laboratory of Molecular Immunology and Immunotherapy, Versiti Blood Research Institute, Milwaukee, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Subramaniam Malarkannan

    Laboratory of Molecular Immunology and Immunotherapy, Versiti Blood Research Institute, Milwaukee, United States
    For correspondence
    subra.malar@bcw.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7511-2731

Funding

National Institutes of Health (AI102893)

  • Subramaniam Malarkannan

National Cancer Institute (CA179363)

  • Subramaniam Malarkannan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Florent Ginhoux, Agency for Science Technology and Research, Singapore

Ethics

Animal experimentation: All mice were maintained in pathogen-free conditions in the Biological Resource Center at the Medical College of Wisconsin. All animal protocols were approved by Institutional Animal Care and Use Committees. The unique animal protocols that are approved by the IACUC and used in this study is: AUA1512.

Version history

  1. Received: August 25, 2019
  2. Accepted: May 8, 2020
  3. Accepted Manuscript published: May 14, 2020 (version 1)
  4. Version of Record published: May 28, 2020 (version 2)

Copyright

© 2020, Yang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,698
    views
  • 449
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Chao Yang
  2. Jason R Siebert
  3. Robert Burns
  4. Yongwei Zheng
  5. Ao Mei
  6. Benedetta Bonacci
  7. Demin Wang
  8. Raul A Urrutia
  9. Matthew J Riese
  10. Sridhar Rao
  11. Karen-Sue Carlson
  12. Monica S Thakar
  13. Subramaniam Malarkannan
(2020)
Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature
eLife 9:e51339.
https://doi.org/10.7554/eLife.51339

Share this article

https://doi.org/10.7554/eLife.51339

Further reading

    1. Immunology and Inflammation
    Xiuyuan Lu, Hiroki Hayashi ... Sho Yamasaki
    Research Article

    SARS-CoV-2 vaccines have been used worldwide to combat COVID-19 pandemic. To elucidate the factors that determine the longevity of spike (S)-specific antibodies, we traced the characteristics of S-specific T cell clonotypes together with their epitopes and anti-S antibody titers before and after BNT162b2 vaccination over time. T cell receptor (TCR) αβ sequences and mRNA expression of the S-responded T cells were investigated using single-cell TCR- and RNA-sequencing. Highly expanded 199 TCR clonotypes upon stimulation with S peptide pools were reconstituted into a reporter T cell line for the determination of epitopes and restricting HLAs. Among them, we could determine 78 S epitopes, most of which were conserved in variants of concern (VOCs). After the 2nd vaccination, T cell clonotypes highly responsive to recall S stimulation were polarized to follicular helper T (Tfh)-like cells in donors exhibiting sustained anti-S antibody titers (designated as ‘sustainers’), but not in ‘decliners’. Even before vaccination, S-reactive CD4+ T cell clonotypes did exist, most of which cross-reacted with environmental or symbiotic microbes. However, these clonotypes contracted after vaccination. Conversely, S-reactive clonotypes dominated after vaccination were undetectable in pre-vaccinated T cell pool, suggesting that highly responding S-reactive T cells were established by vaccination from rare clonotypes. These results suggest that de novo acquisition of memory Tfh-like cells upon vaccination may contribute to the longevity of anti-S antibody titers.

    1. Chromosomes and Gene Expression
    2. Immunology and Inflammation
    Rajan M Thomas, Matthew C Pahl ... Andrew D Wells
    Research Article

    Ikaros is a transcriptional factor required for conventional T cell development, differentiation, and anergy. While the related factors Helios and Eos have defined roles in regulatory T cells (Treg), a role for Ikaros has not been established. To determine the function of Ikaros in the Treg lineage, we generated mice with Treg-specific deletion of the Ikaros gene (Ikzf1). We find that Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibit Th1-like gene expression with abnormal production of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signaling. While Ikzf1-Treg-cko mice do not develop spontaneous autoimmunity, Ikaros-deficient Treg are unable to control conventional T cell-mediated immune pathology in response to TCR and inflammatory stimuli in models of IBD and organ transplantation. These studies establish Ikaros as a core factor required in Treg for tolerance and the control of inflammatory immune responses.